# Study of the Efficacy and Safety of Kalinox® 170 Bar for the Performance of Care Procedures in Children With Burns

> **NCT00643357** · PHASE3 · WITHDRAWN · sponsor: **Air Liquide Santé International**

## Conditions studied

- Burns

## Interventions

- **DRUG:** 50% Oxygen/50% Nitrous oxide premix (KALINOX 170 bar)
- **DRUG:** 50%Oxygen/50% Nitrogen premix

## Key facts

- **NCT ID:** NCT00643357
- **Lead sponsor:** Air Liquide Santé International
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-03
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No patient recruited due to current guidelines for the pain related to burn
- **Last updated:** 2012-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00643357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00643357, "Study of the Efficacy and Safety of Kalinox® 170 Bar for the Performance of Care Procedures in Children With Burns". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00643357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*